Arche Investment Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
13
- Portfolio
-
9
- Exits
-
3
Arche Investment General Information
Company Description
Founded in 2017, Arche Investment is a corporate venture capital arm of Reyon Pharmaceutical based in Seoul, South Korea. The firm seeks to invest in bio-technology sector companies.
Business Details
Website
www.archeinvestment.com/kor/mainYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 15th floor, TwoIFC
- 10, Gukjegeumyung-ro
- Seoul, Yeongdeungpo-gu 07326
- South Korea
Arche Investment Investments (13)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Macro Machine | 01-Oct-2023 | Later Stage VC | Machinery (B2B) | Stealth | ||
| Meta Care | 26-May-2022 | Distributors (Healthcare) | Generating Revenue | |||
| Petdoc | 01-Jan-2022 | Other Services (B2C Non-Financial) | Generating Revenue | |||
| Kasa Korea | 14-Dec-2021 | Brokerage | Generating Revenue | |||
| Cerecin | 14-Sep-2021 | Drug Discovery | Clinical Trials - Phase 3 | |||
| NeogenTC | 05-Apr-2021 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Teraimmune | 15-Oct-2020 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Kasa Korea | 24-Sep-2020 | Brokerage | Generating Revenue | |||
| Enchem | 21-Sep-2020 | Early Stage VC | Specialty Chemicals | Generating Revenue | ||
| In And Out | 30-Mar-2020 | Later Stage VC | Consulting Services (B2B) | Generating Revenue |
Arche Investment Exits (3)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Teraimmune | 29-Jun-2023 | Merger/Acquisition | |
| Kasa Korea | 15-Mar-2023 | ||
| Enchem | 01-Nov-2021 |
Arche Investment Investments by Industry, Year, and Region
Arche Investment Co-Investors (4)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Anchor Equity Partners | 1 |
|
|
||
| H.PIO |
|
|
|||
| Megazone Cloud |
|
|
|||
| The Invention Lab |
|
|
Arche Investment FAQs
-
What is Arche Investment?
Founded in 2017, Arche Investment is a corporate venture capital arm of Reyon Pharmaceutical based in Seoul, South Korea.
-
When was Arche Investment founded?
Arche Investment was founded in 2017.
-
Where is Arche Investment headquartered?
Arche Investment is headquartered in Seoul, South Korea.
-
What is Arche Investment's total asset value?
Arche Investment has around in total assets under management.
-
How many investments has Arche Investment made?
Arche Investment has made 13 investments.
-
What has Arche Investment invested in?
Arche Investment has made numerous investments in companies like Macro Machine, Meta Care, and Petdoc within the Machinery (B2B), Distributors (Healthcare), and Services (B2C Non-Financial) industries.
-
What has Arche Investment invested in recently?
Arche Investment's latest investment was on 01-Oct-2023 in Macro Machine, a company within the Machinery (B2B) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process